Skip to content

Abbott

Recent events

Recent events tied to this brand in public sources.

Back to profile63 entries · Page 3 of 4

  1. 2021

    Abbott launches implantable device for babies with PDA

    Abbott launched a medical device that it claims is the world’s first implantable device for treating patent ductus arteriosus in babies weighing as little as 700 grams, using a minimally invasive procedure.

  2. 2021

    Abbott ends operations at Gurnee test assembly plant

    Abbott ended operations at its Gurnee, Illinois assembly plant, where workers had been manufacturing BinaxNOW COVID-19 tests. Workers were told on Tuesday they no longer needed to report to work.

  3. 2021

    Shanghai regulator fines Abbott trading subsidiary over contaminated food products

    Shanghai's market regulator imposed an administrative penalty on Abbott Trading (Shanghai) Co., Ltd., including a fine of 9,093,140.58 yuan, over the production and sale of food allegedly contaminated by packaging materials, containers, or transport tools.

  4. 2021

    Abbott launches NeuroSphere Virtual Clinic in the U.S.

    Abbott announced the U.S. launch of NeuroSphere Virtual Clinic, a technology that lets patients communicate with physicians and receive neurostimulation treatment settings remotely.

  5. 2021

    Abbott wins U.S. Secretary of State’s Award for Innovation in Rwanda

    Abbott won the 2020 U.S. Secretary of State’s Award for Corporate Excellence in the Innovation category for its work expanding preventative health care in underserved rural areas of Rwanda.

  6. 2021

    Abbott makes BinaxNOW available to schools and workplaces

    Abbott announced that its BinaxNOW COVID-19 rapid antigen test was being made available to schools, universities, pharmacies, and workplaces requiring frequent and affordable testing.

  7. 2020

    FDA approves Abbott HeartMate 3 for pediatric patients

    The U.S. Food and Drug Administration approved updated labeling for Abbott's HeartMate 3 left ventricular assist device for use in pediatric patients with advanced refractory left ventricular heart failure.

  8. 2020

    Abbott launches Similac Pro-Advance in Canada

    Abbott launched Similac Pro-Advance infant formula with 2'-FL, described as the first product of its kind in Canada.

  9. 2020

    Abbott launches FreeStyle Libre in India

    Abbott announced the launch of its FreeStyle Libre continuous glucose monitoring system in India. The system is available to adults and children over four living with diabetes and to women with gestational diabetes.

  10. 2020

    Abbott reports third-quarter 2020 results and raises guidance

    Abbott announced its third-quarter 2020 financial results, reporting worldwide sales of $8.9 billion, and projected full-year adjusted diluted EPS of at least $3.55.

  11. 2020

    FDA authorizes Abbott’s BinaxNOW COVID-19 antigen test

    Abbott said it received Emergency Use Authorization from the U.S. Food and Drug Administration for its BinaxNOW COVID-19 Ag Card portable antigen test.

  12. 2020

    FDA approves Abbott Patient Controller app for compatible Apple smartphones

    Abbott received US Food and Drug Administration approval for use of its Patient Controller app on compatible personal Apple smartphone devices.

  13. 2020

    FDA approves Abbott Gallant ICD and CRT-D devices

    Abbott announced that the U.S. FDA approved its next-generation Gallant implantable cardioverter defibrillator and cardiac resynchronization therapy defibrillator devices.

  14. 2020

    Abbott shifts some distribution channels to new distributors

    Abbott said it would transfer some distribution channels to new distributors, affecting Meikang Bio's agency business for imported products.

  15. 2020

    Abbott announces a planned increase in daily test production

    Abbott said it was ramping up production with a plan to deliver 50,000 ID NOW COVID-19 tests per day to the U.S. healthcare system beginning the following week.

  16. 2020

    Dignity Health launches rapid COVID-19 testing in Northern California

    Dignity Health began rapid COVID-19 testing at six hospitals across Northern California, with results available in about 30 minutes. The service was described as a partnership with Abbott.

  17. 2020

    Abbott unveils rapid coronavirus test

    Abbott unveiled a portable coronavirus test that can detect infection in as little as five minutes. The company said it planned to supply 50,000 tests a day starting Wednesday.

  18. 2020

    FDA authorizes Abbott COVID-19 test

    The FDA issued an emergency use authorization to Abbott Laboratories for its COVID-19 molecular test.

  19. 2020

    Abbott launches quadrivalent influenza vaccine in India

    Abbott said it launched a new inactivated quadrivalent influenza vaccine in India, offering protection against four virus strains.

  20. 2020

    Abbott receives CE Mark for Gallant devices

    Abbott announced that it had received CE Mark for its Gallant implantable cardioverter defibrillator and cardiac resynchronization therapy defibrillator devices, enabling their introduction in Europe.